Yutaka Yonemura

Kishiwada Tokushukai Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Yutaka Yonemura is a pioneering surgeon whose career has been defined by advancing the treatment of peritoneal surface malignancies, particularly pseudomyxoma peritonei (PMP). His research focuses on the development and refinement of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), complex procedures that offer the only chance for long-term survival in patients with advanced abdominal cancers. A major contribution is his exploration of minimally invasive approaches to these traditionally open surgeries. In his 2024 pilot study, Dr. Yonemura demonstrated the feasibility of robot-assisted CRS with upper-abdominal peritonectomy for PMP patients with a low peritoneal carcinomatosis index. This work is pivotal, as it suggests that robotic technology can reduce the morbidity of these extensive operations without compromising oncologic outcomes. While his most cited paper is recent, his broader body of work has been instrumental in establishing the global standards for peritoneal cancer management. Dr. Yonemura’s innovative spirit and technical expertise continue to shape the future of surgical oncology, offering new hope and less invasive options for patients facing these challenging diagnoses.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of Robot-Assisted Cytoreductive Surgery With Upper-Abdominal Peritonectomy for Pseudomyxoma Peritonei With Low Peritoneal Carcinomatosis Index: A Pilot Study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Kishiwada Tokushukai Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago